Tag - PALFORZIA

An advisory committee of the FDA voted to support the use of Aimmune Therapeutics’ (NASDAQ:AIMT) PALFORZIA in children and teens with peanut allergy.  The committee voted seven-to-two that the efficacy data and eight-to...